Polaris
Polaris is a French food-technology company producing highly concentrated Omega-3 EPA/DHA oils from marine and microalgae sources via proprietary stabilization, sensory, and concentration technologies, selling B2B ingredients and toll-manufacturing services to nutraceutical, food, infant nutrition, and cosmetics manufacturers worldwide.
- Company typePrivate
- Founded1994
- HeadquartersQuimper, France
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Polaris does
Polaris is a French food-technology company founded in 1994 and headquartered in Quimper, France, specializing in the production of highly concentrated Omega-3 oils rich in EPA and DHA, sourced from both marine (fish) and microalgae origins. The company operates its own high-tech lipochemistry manufacturing facility in La Forêt-Fouesnant, Brittany — operational since 2012 — and has built a layered proprietary technology stack anchored by Qualitysilver® (a patented, 5th-generation stabilization process providing 2–7× higher oxidation resistance than standard oils), Sensory® (an organoleptic concept that eliminates fishy taste and odor in finished products), Greensilver® (concentration technologies spanning molecular distillation, supercritical fluid CO2 extraction, and enzymatic synthesis), and the more recent Qualisens delivery technology. The technology estate is reinforced by an original 1994 international patent on enzymatic enrichment of fatty acids and by a dense portfolio of international certifications (IFOS 5-star, US FDA GRAS, ISO 9001:2015, ISO 22000:2005, Halal, Kosher, Vegan, Friend of the Sea).
Polaris generates revenue through two B2B streams: (1) sales of branded Omega-3 ingredients under the Omegavie® family — Omegavie Marine for fish-derived oils and Omegavie Algae for plant-based microalgae oils — to nutraceutical, functional food, infant nutrition, and cosmetics manufacturers; and (2) toll-manufacturing / contract services that leverage the company's molecular distillation and refining capabilities to purify, concentrate, decontaminate, and deodorize marine and vegetable oils for third parties. The go-to-market is sales-led, anchored in direct enterprise engagement and an active global trade-show presence (Vitafoods Europe/Asia/India, In-Cosmetics, Supply Side Global, FI Asia China), with regional distribution partnerships — most notably Golden Omega USA for North America — supporting cross-border reach. Pricing is quote-based with multi-year contracts; the company reported €30 million in annual revenue in 2022 and has subsequently raised €5 million (2021) for capacity doubling and Asia/US expansion, launched the world's first DPA-containing Omega-3 oil (100 500 DPA) and a vegan krill alternative (Krill-Like Algae) in 2025, and continues to position itself as the French leader in concentrated EPA/DHA ingredients and a key player in GreenTech.
Polaris firmographics
Firmographics- Name
- Polaris
- Legal name
- POLARIS
- Website
- https://www.polaris.fr/
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Polaris is a French food-technology company producing highly concentrated Omega-3 EPA/DHA oils from marine and microalgae sources via proprietary stabilization, sensory, and concentration technologies, selling B2B ingredients and toll-manufacturing services to nutraceutical, food, infant nutrition, and cosmetics manufacturers worldwide.
- Ownership category
- akta.pro rank
Polaris industry classification
Industry- Product category
- Omega-3 Ingredient Manufacturing
- NAICS
- Fats and Oils Refining and Blending (311225), Starch and Vegetable Fats and Oils Manufacturing (31122)
- SIC
- Fats & Oils (2070), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids) (AFAJAKAC)
- akta.pro secondary industry
- Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates) (AFAJALAK)
Keywords
Where Polaris is headquartered
LocationHeadquarters
- HQ city
- Quimper
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Polaris business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Omega-3 Ingredients Sales: Sale of proprietary Omega-3 ingredient products including Omegavie Marine (fish oils) and Omegavie Algae (microalgae oils) to nutraceutical, food, infant nutrition, and cosmetics manufacturers. Revenue of €30M in 2022 with strong international presence.
- Toll Manufacturing Services: Contract manufacturing services leveraging over 30 years of expertise in molecular distillation and refining processes. Offers purification, concentration, decontamination, and deodorization services for marine and vegetable oils.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B ingredients and toll manufacturing services with customized pricing |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Polaris product offering
Product offeringCore offering
Polaris develops, manufactures, and sells concentrated Omega-3 EPA/DHA ingredient oils for use by nutraceutical, functional food, infant nutrition, and cosmetics manufacturers, drawing on proprietary stabilization (Qualitysilver®), organoleptic (Sensory®), and concentration (Greensilver®, Qualisens®) technologies. The company produces these ingredients at its own high-tech lipochemistry facility in Brittany from sustainably sourced marine (fish) and plant-based (microalgae) raw materials. It also offers contract (toll) manufacturing services using molecular distillation for purification, concentration, decontamination, and deodorization of marine and vegetable oils.
Product overview
Polaris offers a portfolio of Omega-3 ingredient solutions centered on its Omegavie brand sub-products (Omegavie Marine for fish oils and Omegavie Algae for vegan microalgae oils), complemented by proprietary stabilization (Qualitysilver), organoleptic performance (Sensory), and concentration (Greensilver) technologies. The company also provides customized toll manufacturing services using molecular distillation. Recent innovations include 100 500 DPA (the only Omega-3 oil containing DPA), Qualisens (proprietary delivery technology), and Krill-Like Algae (vegan krill alternative). Products are sold as ingredients to nutraceutical, functional food, infant nutrition, and cosmetics manufacturers.
Differentiator
Problem solved
Functional benefit
Products and services
- Omegavie Marine Marine (fish) Omega-3 oils rich in EPA and DHA, manufactured in France from sustainably sourced raw materials with unequalled oxidation stability and organoleptic quality. Sold as an ingredient to nutraceutical, food, infant nutrition, and cosmetics manufacturers.
- Omegavie Algae Microalgae oils rich in DHA and EPA, processed and highly concentrated in France. A vegan and sustainable alternative to fish oils, allergen-free with excellent organoleptic qualities. Sold as an ingredient to nutraceutical, food, infant nutrition, and cosmetics manufacturers.
- Omegavie DHA 700 Algae
Quantifiable outcome
- Stability 2-7x higher than standard oils via Qualitysilver® technology
- +2 more outcomes
Companies that use Polaris
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
Polaris technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Polaris partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Golden Omega USAcorePolaris partnered with Golden Omega USA to distribute high-quality plant-based Omega-3 solutions in North America. Golden Omega's expertise in the North American territory enables Polaris to expand its commercial reach. The partnership allows Polaris to serve the growing demand for sustainable vegan Omega-3 alternatives in the US market.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Polaris competitors and assessment
Company assessmentBroad incumbents
- DSM-firmenich: Global nutrition and specialty ingredients giant with the life's™OMEGA range of EPA/DHA concentrates (both fish and algal). Competes with Polaris across the same nutraceutical, food, and infant nutrition channels but at vastly larger scale and broader product portfolio.
- Croda International: UK-based specialty chemicals and ingredients company with Incromega™ Omega-3 concentrates for nutrition and personal care. Overlaps with Polaris's Omegavie product line and serves many of the same infant nutrition and nutraceutical accounts.
- BASF: Global chemicals giant with a substantial nutrition and health ingredients portfolio including Omega-3 fatty acids. Provides scale competition in food, infant nutrition, and dietary supplement channels where Polaris competes.
- Corbion: Specialty food ingredients and algae fermentation specialist with AlgaPrime™ DHA from algae and broader Omega-3 offerings. Comparable to Polaris's Omegavie Algae vegan Omega-3 business with strong sustainability credentials.
Direct peers
- Aker BioMarine: Norwegian krill oil specialist with Superba™ krill and an expanding EPA/DHA ingredient portfolio. Closely comparable to Polaris as a premium-positioned marine-derived Omega-3 supplier selling to nutraceutical brands, with growing focus on sustainable/eco-certified sourcing.
- KD Pharma Group: Specialty Omega-3 concentrate manufacturer offering toll processing and custom EPA/DHA concentrates via molecular distillation. Overlaps directly with Polaris on concentration technology (Greensilver®) and toll-manufacturing services.
- Golden Omega: Chilean Omega-3 concentrate producer and Polaris's North American distribution partner. Highly comparable in EPA/DHA concentrate offering and sustainability positioning (Friend of the Sea certified), serving the same nutraceutical customers globally.
- Epax (Pelagia): Norwegian producer of concentrated Omega-3 EPA/DHA oils for supplements, food, and infant nutrition with strong toll-manufacturing capabilities. Direct overlap with Polaris's molecular distillation concentrates and Qualitysilver®-style oxidation stability story.
- GC Rieber VivoMega: Norwegian Omega-3 concentrate producer offering marine and algae-derived EPA/DHA for nutraceutical and food applications. Comparable to Polaris in size, sustainability positioning, and B2B ingredient focus.
Emerging players
- Algalíf: Iceland-based producer of natural astaxanthin and algae-derived Omega-3 (DHA/EPA). A smaller-scale, sustainability-focused direct comparable to Polaris's microalgae ingredient business, serving nutraceutical brands globally.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Polaris social profiles
Digital presencePolaris compliance and trust
Trust signalCompliance10 records
Polaris financial estimates
Financial estimateRevenue estimate
Valuation estimate
Polaris leadership team
Management profileNumber of profiles
Profiles8 records
Polaris funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Polaris M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Polaris
What does Polaris do?
Polaris develops, manufactures, and sells concentrated Omega-3 EPA/DHA ingredient oils for use by nutraceutical, functional food, infant nutrition, and cosmetics manufacturers, drawing on proprietary stabilization (Qualitysilver®), organoleptic (Sensory®), and concentration (Greensilver®, Qualisens®) technologies. The company produces these ingredients at its own high-tech lipochemistry facility in Brittany from sustainably sourced marine (fish) and plant-based (microalgae) raw materials. It also offers contract (toll) manufacturing services using molecular distillation for purification, concentration, decontamination, and deodorization of marine and vegetable oils.
Is Polaris a public or private company?
Polaris is a private company. It is classified as venture growth investor backed and is currently operating.
When was Polaris founded?
Polaris was founded in 1994. It employs 1 to 10 people.
Where is Polaris based?
Polaris is headquartered in Quimper, France, in the Europe region.
How does Polaris make money?
Two revenue lines are on record. Omega-3 Ingredients Sales are the primary driver. The others are toll Manufacturing Services.
Who are Polaris's main competitors?
Broad incumbents on record are DSM-firmenich, Croda International, BASF and Corbion. Direct peers are Aker BioMarine, KD Pharma Group, Golden Omega, Epax (Pelagia) and GC Rieber VivoMega. Algalíf is listed as an emerging player.
Does Polaris have an API?
No public API is recorded for Polaris.
What industry is Polaris in?
Polaris's product category is Omega-3 Ingredient Manufacturing. Its primary akta.pro industry code is AFAJAKAC, Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids), with a secondary code of AFAJALAK, Omega-3 & Marine/Algal Lipids (EPA/DHA Oils, Concentrates). Its NAICS code is 311225 and its SIC code is 2070.